CLINUVEL PHARMACEUTICALS LTD (CUV) reported its annual financial results for the year ended 30 June 2018, with the Group achieving its second consecutive profitable year. Net profits before tax increased 82% on the previous financial year to $12.937m on revenue growth of 52%. Total revenues for the year were $25.750m. The Group concluded the year with $36.198m in cash and financial assets, with current liabilities of $3.470m.
http://crweworld.com/article/news-p...vel-delivers-second-positive-financial-result
CLINUVEL PHARMACEUTICALS LTD (CUV) reported its annual financial...
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add CUV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.28 |
Change
-0.250(1.85%) |
Mkt cap ! $741.1M | |||
| Open | High | Low | Value | Volume |
| $13.55 | $13.62 | $13.25 | $1.157M | 86.45K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 227 | $13.28 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.42 | 228 | 1 |
View Market Depth
| Last trade - 16.10pm 15/11/2024 (20 minute delay) ? |
| CUV (ASX) Chart |
